sulfamethoxazole has been researched along with Mouth Breathing in 1 studies
Sulfamethoxazole: A bacteriostatic antibacterial agent that interferes with folic acid synthesis in susceptible bacteria. Its broad spectrum of activity has been limited by the development of resistance. (From Martindale, The Extra Pharmacopoeia, 30th ed, p208)
sulfamethoxazole : An isoxazole (1,2-oxazole) compound having a methyl substituent at the 5-position and a 4-aminobenzenesulfonamido group at the 3-position.
Mouth Breathing: Abnormal breathing through the mouth, usually associated with obstructive disorders of the nasal passages.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Marks, NJ | 1 |
| Mills, RP | 1 |
| Shaheen, OH | 1 |
1 trial available for sulfamethoxazole and Mouth Breathing
| Article | Year |
|---|---|
A controlled trial of cotrimoxazole therapy in serous otitis media.
Topics: Child; Child, Preschool; Clinical Trials as Topic; Double-Blind Method; Drug Combinations; Female; H | 1981 |